Expression of c-myc and PCNA in Epstein-Barr virus-associated gastric carcinoma

Experimental and Therapeutic Medicine

Volumn 5, Issue 4, 2013, Pages 1030-1034

  Zhu, Shiguang ^a   Sun, Ping ^a   Zhang, Yingxin ^b   Yan, Liping ^c   Luo, Bing ^d  

^a YANTAI YUHUANGDING HOSPITAL   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

^c QINGDAO CENTRAL HOSPITAL   (China)

^d QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

c myc; Epstein Barr virus; Immunohistochemistry; Progressive genes; Proliferating cell nuclear antigen; Reverse transcription polymerase chain reaction; Stomach neoplasm

Indexed keywords

COMPLEMENTARY DNA; CYCLINE; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; GLYCERALDEHYDE 3 PHOSPHATE; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; MYC PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SOUTHERN BLOTTING; STOMACH CARCINOMA;

EID: 84874636239     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.972     Document Type: Article

References (12)

1. Shah KM and Young LS: Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 15: 982-988, 2009.
2. Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC, Wang HP and Lin JT: Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 118: 1031-1038, 2000.
3. Akiba S, Koriyama C, Herrera-Goepfert R and Eizuru Y: Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci 99: 195-201, 2008.
4. Sugiura M, Imai S, Tokunaga M, et al: Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br J Cancer 74: 625-631, 1996.
5. zur Hausen A, Brink AA, Craanen ME, et al: Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric carcinomas: expression of the transforming BARF1 gene. Cancer Res 60: 2745-2748, 2000.
6. Oudejans JJ, van den Brule AJ, Jiwa NM, et al: BHRF1, the Epstein-Barr virus (EBV) homologue of the bcl-2 protooncogene, is transcribed in EBV associated B-cell lymphomas and in reactive lymphocytes. Blood 86: 1893-1902, 1995.
7. Ishii H, Gobe G, Kawakubo Y, et al: Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins. Histopathology 38: 111-119, 2001.
8. Yang J, Deng X, Deng L, et al: Epstein-Barr virus LMP1 activates human telomerase transcription via c-myc expression. Chinese Journal of Virology 19: 240-244, 2003.
9. Li Z and Zong Y: Effects of LMP-1 expression on neoplastic cell proliferation and apoptosis in nasopharyngeal carcinoma. Zhonghua Bing Li Xue Za Zhi 28: 340-343, 1999 (In Chinese).
10. Sheng W, Decaussin G, Sumner S, et al: N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene 20: 1176-1185, 2001.
11. Sheng W, Decaussin G, Ligout A, et al: Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol 77: 3859-3865, 2003.
12. Huang H, Pan X and Yu L: The effect of Epstein-Barr virus gene BHRF1 expression on the apoptotic resistance of nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi 20: 245-247, 1998 (In Chinese).